Product NDC: | 31722-225 |
Proprietary Name: | Gemfibrozil |
Non Proprietary Name: | Gemfibrozil |
Active Ingredient(s): | 600 mg/1 & nbsp; Gemfibrozil |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 31722-225 |
Labeler Name: | Camber Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077836 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110101 |
Package NDC: | 31722-225-60 |
Package Description: | 24 BOTTLE in 1 CASE (31722-225-60) > 60 TABLET in 1 BOTTLE |
NDC Code | 31722-225-60 |
Proprietary Name | Gemfibrozil |
Package Description | 24 BOTTLE in 1 CASE (31722-225-60) > 60 TABLET in 1 BOTTLE |
Product NDC | 31722-225 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Gemfibrozil |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110101 |
Marketing Category Name | ANDA |
Labeler Name | Camber Pharmaceuticals |
Substance Name | GEMFIBROZIL |
Strength Number | 600 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |